Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02076191
Title Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors John Mascarenhas
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University of St. Louis Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Wake Forest University Baptist Medical Center Winston-Salem North Carolina 27157 United States Details
Cleveland Clinic Taussig Cancer Center Institute Cleveland Ohio 44195 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field